Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Ginekologia Polska
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 93, No 8 (2022)
Research paper
Published online: 2022-06-03
View PDF Download PDF file View HTML
Get Citation

Transcervical intrauterine radiofrequency ablation of fibroids in high-risk patients with bleeding disorder

Elvin Piriyev1, Ralf Bends2, Sven Schiermeier3, Thomas Romer2
DOI: 10.5603/GP.a2022.0042
·
Pubmed: 35894488
·
Ginekol Pol 2022;93(8):614-619.
Affiliations
  1. Department of Obstetrics and Gynecology, University Witten-Herdecke, Department of Obstetrics and Gynecology, Academic Hospital Cologne Weyertal University of Cologne, Germany
  2. Department of Obstetrics and Gynecology Academic Hospital Cologne Weyertal University of Cologne, Germany
  3. Department of Obstetrics and Gynecology, University Witten-Herdecke, Marien-Hospital, Witten Marienplatz, Witten, Germany

open access

Vol 93, No 8 (2022)
ORIGINAL PAPERS Gynecology
Published online: 2022-06-03

Abstract

Objectives: To show the advantages of transcervical radiofrequency ablation (TRFA) in high-risk patients with bleeding disorder.

Material and methods: It is a retrospective analysis. The study included only patients with known pre-existing conditions (obesity, cardiac and neurological disease, coagulation disorder, anaemia) or post-surgical conditions who were treated with the Sonata® System for fibroid-related bleeding complaints at Academic Hospital Cologne Weyertal between January 2015 and March 2021. These patients were classified as high-risk patients. The fibroids were mostly determined due transvaginal sonography. Thirty patients were included, and 43 fibroids were determined.

Results: Therapy with the Sonata® system could be performed without complications in all cases. In our analysis, improvement of fibroid-related symptoms was observed in 89% of cases.

Conclusions: The Sonata® System is on the one hand minimally invasive, uncomplicated and fast and on the other hand a successful method of fibroid therapy, which is particularly suitable for high-risk patients with various pre-existing conditions, for whom a minimally invasive, bloodless and short surgical procedure has great advantages.

Abstract

Objectives: To show the advantages of transcervical radiofrequency ablation (TRFA) in high-risk patients with bleeding disorder.

Material and methods: It is a retrospective analysis. The study included only patients with known pre-existing conditions (obesity, cardiac and neurological disease, coagulation disorder, anaemia) or post-surgical conditions who were treated with the Sonata® System for fibroid-related bleeding complaints at Academic Hospital Cologne Weyertal between January 2015 and March 2021. These patients were classified as high-risk patients. The fibroids were mostly determined due transvaginal sonography. Thirty patients were included, and 43 fibroids were determined.

Results: Therapy with the Sonata® system could be performed without complications in all cases. In our analysis, improvement of fibroid-related symptoms was observed in 89% of cases.

Conclusions: The Sonata® System is on the one hand minimally invasive, uncomplicated and fast and on the other hand a successful method of fibroid therapy, which is particularly suitable for high-risk patients with various pre-existing conditions, for whom a minimally invasive, bloodless and short surgical procedure has great advantages.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

Sonata®; fibroid; ablation; high risk patients; bleeding disorder; uterus

About this article
Title

Transcervical intrauterine radiofrequency ablation of fibroids in high-risk patients with bleeding disorder

Journal

Ginekologia Polska

Issue

Vol 93, No 8 (2022)

Article type

Research paper

Pages

614-619

Published online

2022-06-03

Page views

3947

Article views/downloads

525

DOI

10.5603/GP.a2022.0042

Pubmed

35894488

Bibliographic record

Ginekol Pol 2022;93(8):614-619.

Keywords

Sonata®
fibroid
ablation
high risk patients
bleeding disorder
uterus

Authors

Elvin Piriyev
Ralf Bends
Sven Schiermeier
Thomas Romer

References (33)
  1. Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017; 124(10): 1501–1512.
    CrossRefPubMed
  2. Römer T. Medical treatment of fibroids. De Gruyter. : 2019.
  3. Foth D, Röhl FW, Friedrich C, et al. Symptoms of uterine myomas: data of an epidemiological study in Germany. Arch Gynecol Obstet. 2017; 295(2): 415–426.
    CrossRefPubMed
  4. Zimmermann A, Bernuit D, Gerlinger C, et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health. 2012; 12: 6.
    CrossRefPubMed
  5. Nelson AL, Ritchie JJ. Severe anemia from heavy menstrual bleeding requires heightened attention. Am J Obstet Gynecol. 2015; 213(97): e1–97.e6.
    CrossRefPubMed
  6. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol. 2002; 99(2): 229–234.
    CrossRefPubMed
  7. Wise LA, Palmer JR, Stewart EA, et al. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005; 105(3): 563–568.
    CrossRefPubMed
  8. Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010; 152(1): 96–102.
    CrossRefPubMed
  9. Borah BJ, Nicholson WK, Bradley L, et al. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013; 209(4): 319.e1–319.e20.
    CrossRefPubMed
  10. Munro MG, Critchley HOD, Broder MS, et al. FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011; 113(1): 3–13.
    CrossRefPubMed
  11. Bradley LD, Pasic RP, Miller LE. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. J Laparoendosc Adv Surg Tech A. 2019; 29(12): 1507–1517.
    CrossRefPubMed
  12. Iversen H, Dueholm M. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions. J Minim Invasive Gynecol. 2017; 24(6): 1020–1028.
    CrossRefPubMed
  13. Lin L, Ma H, Wang J, et al. Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis. J Minim Invasive Gynecol. 2019; 26(3): 409–416.
    CrossRefPubMed
  14. Toub DB. A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System. Curr Obstet Gynecol Rep. 2017; 6(1): 67–73.
    CrossRefPubMed
  15. Bongers M, Brölmann H, Gupta J, et al. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg. 2015; 12(1): 61–70.
    CrossRefPubMed
  16. Chudnoff S, Guido R, Roy K, et al. Ultrasound-Guided Transcervical Ablation of Uterine Leiomyomas. Obstet Gynecol. 2019; 133(1): 13–22.
    CrossRefPubMed
  17. Römer T, Bends R, Christoffel L, et al. The significance of transcervical ultrasound-guided radiofrequency ablation in the treatment of symptomatic fibroids: results of an expert consensus from German-speaking countries. Arch Gynecol Obstet. 2022 [Epub ahead of print].
    CrossRefPubMed
  18. Piriyev E, Schiermeier S, Römer T. Combined procedure of the transcervical radiofrequency ablation (TRFA) system and surgical hysteroscopy. Increased risk or safe procedure? Videosurgery and Other Miniinvasive Techniques. 2022.
    CrossRef
  19. Lukes A, Green MA. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata. J Gynecol Surg. 2020; 36(5): 228–233.
    CrossRefPubMed
  20. Garza-Leal JG. Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study. J Gynecol Surg. 2019; 35(1): 19–23.
    CrossRefPubMed
  21. Davis MR, Soliman AM, Castelli-Haley J, et al. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids. J Womens Health (Larchmt). 2018; 27(10): 1204–1214.
    CrossRefPubMed
  22. Vercellini P, Cortesi I, Oldani S, et al. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod. 1997; 12(8): 1768–1771.
    CrossRefPubMed
  23. Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol. 1993; 82(5): 736–740.
    PubMed
  24. Römer T. Operative Hysteroscopy: A Practical Guide. 2 Edition. De Gruyter, https://doi.org/10.1515/9783110225006 2011.
  25. Revaux A, Ducarme G, Luton D. [Prevention of intrauterine adhesions after hysteroscopic surgery]. Gynecol Obstet Fertil. 2008; 36(3): 311–317.
    CrossRefPubMed
  26. Jin C, Hu Y, Chen X, et al. Laparoscopic versus open myomectomy–a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2009; 145: 14–21.
  27. Altgassen C, Kuss S, Berger U, et al. Complications in laparoscopic myomectomy. Surg Endosc. 2006; 20(4): 614–618.
    CrossRefPubMed
  28. Malzoni M, Rotond M, Perone C, et al. Fertility after laparoscopic myomectomy of large uterine myomas: operative technique and preliminary results. Eur J Gynaecol Oncol. 2003; 24(1): 79–82.
    PubMed
  29. Mettler L, Schollmeyer T, Tinelli A, et al. Complications of Uterine Fibroids and Their Management, Surgical Management of Fibroids, Laparoscopy and Hysteroscopy versus Hysterectomy, Haemorrhage, Adhesions, and Complications. Obstet Gynecol Int. 2012; 2012: 791248.
    CrossRefPubMed
  30. Sizzi O, Rossetti A, Malzoni M, et al. Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol. 2007; 14(4): 453–462.
    CrossRefPubMed
  31. Milad MP, Milad EA. Laparoscopic morcellator-related complications. J Minim Invasive Gynecol. 2014; 21(3): 486–491.
    CrossRefPubMed
  32. Tanos V, Socolov R, Demetriou P, et al. Implementation of minimal invasive gynaecological surgery certification will challenge gynaecologists with new legal and ethical issues. Facts Views Vis Obgyn. 2016; 8(2): 111–118.
    PubMed
  33. Driessen SRC, Sandberg EM, Rodrigues SP, et al. Identification of risk factors in minimally invasive surgery: a prospective multicenter study. Surg Endosc. 2017; 31(6): 2467–2473.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl